CFO4Life Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,275
| Closed | -$939K | – | 159 |
|
|
2021
Q3 | $939K | Sell |
2,275
-63
| -3% | -$26K | 0.22% | 51 |
|
|
2021
Q2 | $865K | Buy |
2,338
+7
| +0.3% | +$2.59K | 0.2% | 56 |
|
|
2021
Q1 | $676K | Sell |
2,331
-67
| -3% | -$19.4K | 0.17% | 65 |
|
|
2020
Q4 | $599K | Sell |
2,398
-104
| -4% | -$26K | 0.17% | 67 |
|
|
2020
Q3 | $567K | Buy |
2,502
+500
| +25% | +$113K | 0.19% | 56 |
|
|
2020
Q2 | $349K | Sell |
2,002
-648
| -24% | -$113K | 0.13% | 75 |
|
|
2020
Q1 | $334K | Buy |
+2,650
| New | +$334K | 0.18% | 78 |
|